Send Inquiry

Request To Call Back

Bortesam Bortezomib Injection IP

Name: Bortesam Bortezomib Injection IP
Brand: Maheshwari Medical Agency
Price: 1000 INR
Availability: InStock

Price 1000 INR/ Pack

Get a Price/Quote

MOQ : 2 Packs

Bortesam Bortezomib Injection IP Specification

Dosage Form
Injection

Indication
Multiple myeloma and mantle cell lymphoma

Salt Composition
Bortezomib IP

Feature
Proteasome inhibitor; sterile; ready to reconstitute

Ingredients
Bortezomib

Application

Ph Level
Neutral pH (Typically 5.0-7.0 for injectable solutions)

Physical Color/Texture
Lyophilized powder, white to off-white

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from light

Shelf Life
2 years

Available Strength
2 mg per vial

Brand Name
Bortesam

Route of Administration
Intravenous or subcutaneous

Adverse Effects
Peripheral neuropathy, thrombocytopenia, hypotension

Registration/Approval
Manufactured in accordance with Indian Pharmacopoeia (IP) standards

Contraindication
Hypersensitivity to bortezomib or boron

Prescription Requirement
Prescription only

Pack Size
Single dose vial

Compatibility
Compatible with normal saline or sterile water for injection

Reconstitution
Required before administration with appropriate diluent

Bortesam Bortezomib Injection IP Trade Information

Minimum Order Quantity
2 Packs

Payment Terms
Cash Advance (CA)

Supply Ability
100 Packs Per Week

Delivery Time
1 Week

Main Domestic Market
All India

About Bortesam Bortezomib Injection IP

Bortesam Bortezomib Injection IP can suppress the growth of many cancer cells, which can lead to deadly condition. This is useful to treat several conditions known as myeloma as well as mantle cell lymphoma. Offered cancer medications are necessary for the successful treatment of cancer and contribute the speedy recovery of patients. Bortesam Bortezomib Injection IP is a solution administered to the patients via an injection; both intravenous or subcutaneous. Useful for many clinical trials, these optimum-grade medicates of safe utilization are necessary for various therapeutic efficacy.

Specification

Manufactured By	Samarth
Packaging Type	Box
Brand	Bortesam
Form of Medicine	Injection
Certification	FDA

Versatile Administration and Ready-to-Use Formulation

Bortesam Bortezomib Injection IP offers flexibility in cancer management by supporting both intravenous and subcutaneous administration routes. The product is presented as a sterile, lyophilized powder for convenient reconstitution with normal saline or sterile water, making it suitable for various clinical settings. Its neutral pH further ensures compatibility and stability during preparation and administration.

High Standards and Shelf Stability

Manufactured under Indian Pharmacopoeia guidelines, Bortesam assures consistent quality and safety for healthcare professionals and patients. With proper storage below 25C and protection from light, the injection maintains its effectiveness for up to two years, ensuring reliability and ease of inventory management for distributors and medical facilities in India.

FAQs of Bortesam Bortezomib Injection IP:

Q: How should Bortesam Bortezomib Injection IP be prepared before administration?

A: The injection comes as a lyophilized powder and must be reconstituted with a compatible diluent, such as normal saline or sterile water for injection, immediately before use. Follow your healthcare providers instructions on preparation to ensure safe and effective administration.

Q: What are the main indications for the use of Bortesam Bortezomib Injection?

A: Bortesam is primarily indicated for treating multiple myeloma and mantle cell lymphoma as part of antineoplastic chemotherapy. Its mechanism as a proteasome inhibitor helps manage these malignancies efficiently.

Q: When and where should Bortesam be administered?

A: Bortesam is administered in a clinical or hospital setting by a qualified healthcare professional, either intravenously or subcutaneously. The timing and frequency will be determined by your doctor based on your treatment plan.

Q: What precautions should be taken when using Bortesam Bortezomib Injection?

A: Bortesam should not be used in individuals with known hypersensitivity to bortezomib or boron. It must only be used under medical supervision, with monitoring for potential adverse effects such as peripheral neuropathy, thrombocytopenia, or hypotension.

Q: What are the storage and shelf life instructions for Bortesam?

A: Store the injection below 25C and protect it from light. With these conditions maintained, the product has a shelf life of up to two years, as per the manufacturers specifications.

Q: What benefits does Bortesam offer for chemotherapy treatment?

A: Bortesam provides targeted proteasome inhibition, contributing to the effective management of specific cancers like multiple myeloma and mantle cell lymphoma. Its sterile, ready-to-reconstitute formulation promotes ease of use and dosing accuracy in clinical settings.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number